Search PubMed⌕ Search

Biomedical subjects

K Hoshina

Publications and source records attributed to K Hoshina.

At least 55 records · Page 3Linked to original sources
PubMed1990

[Comparison between two systems for assaying the level of antibody against Streptococcus agalactiae (GBS) type III].

Levels of antibody against GBS type III in pregnant women have been determined using ELISA assay method that we originally deviced. Toyo Jozo Co. have also introduced an assay system (the Toyo kit) that resembles ours. The present study was performed to compare our system with the Toyo kit. Correctivity between the two systems was good, giving a regression curve of Y = 1.18X - 0.60 and a correlation coefficient of r = 0.794. Antibody levels in pregnant women were determined by the Toyo kit, and were found to be less than 10 micrograms/ml in almost all samples. Among 19 serum samples from vaginal carriers of GBS type III, the antibody levels ranged from 1.5 to 93.8 micrograms/ml. Among seven maternal serum samples in cases of GBS type III infection, the maximum level was 6.0 micrograms/ml. Thus, the Toyo kit showed satisfactory sensitivity for determining the level of antibody against GBS type III. Hereafter, we intend to use the Toyo kit for determining antibody levels in pregnant women.

Antibodies, Bacterial↗
PubMed1988

Effect of a new anti-ulcer drug, (3-[p-(trans-4-aminomethylcyclohexylcarbonyl)-phenyl] propionic acid hydrochloride, TEI-5103) on prostaglandin (PG) levels in rat gastric mucosa.

1. Effect of TEI-5103 on the levels of various prostaglandins (PG's) in rat gastric mucosa was studied by HPLC and RIA methods. 2. When administrated in vivo, TEI-5103 significantly increased the level of prostaglandin E2 (PGE2) but only slightly increased that of prostaglandin I2 (PGI2) or thromboxane A2 (TXA2). 3. In the water-immersion stress model, the PGE2 level in control animals was increased immediately after stress and then decreased gradually to the initial level. Indomethacin (5 mg/kg, s.c.) sustained a lower PGE2 level during the experiment, as well as aggravated the lesions. 4. TEI-5103 (400 mg/kg, p.o.) increased the PGE2 level just before stress, and it resulted in the prevention of lesion formation. 5. TEI-5103 inhibited the activity of 15-OH-PG-dehydrogenase from guinea pig lungs, but did not affect the activity of phospholipase A2 from porcine pancreas.

Animals↗
PubMed1988

Lack of correlation between haemagglutination and adherence to epithelial cells in Yersinia pseudotuberculosis.

Yersinia pseudotuberculosis was examined for its haemagglutinating activity and adherence to cultured epithelial cells (HEp-2) in relation to possession of a virulence (VW) plasmid and to growth conditions. VW-lacking (VW-) bacteria were isolated from ten VW+ strains of each serovar which, after they were grown on CFA plates at 37 degrees C, agglutinated the erythrocytes from five different species. In contrast to the bacteria possessing the plasmid (VW+) half of the VW- bacteria, grown on CFA plates at 37 degrees C, did not agglutinate any of the erythrocytes used and the other half agglutinated only human erythrocytes. Furthermore, when grown on CFA plates at 25 degrees C, neither VW+ nor VW- bacteria showed a haemagglutinating activity. When the bacteria were grown in CFA broth, only two strains grown at 25 degrees C did not agglutinate any of the erythrocytes tested. The VW+ and VW- bacteria of the remaining strains, grown either at 25 degrees C or 37 degrees C, showed relatively high haemagglutinating activity. Adherence to HEp-2 cells did not correlate with haemagglutinating activity in Y. pseudotuberculosis; the VW+ bacteria grown at 37 degrees C adhered to HEp-2 cells more efficiently than either the VW- derivatives or the VW+ bacteria grown at 25 degrees C, regardless of the growth medium. These results indicate that some of the haemagglutinins detected on Y. pseudotuberculosis are not involved in the adherence to HEp-2 cells.

Animals↗
PubMed1987

Raw beef, pork and chicken in Japan contaminated with Salmonella sp., Campylobacter sp., Yersinia enterocolitica, and Clostridium perfringens--a comparative study.

One hundred and twenty samples each of raw ground beef, pork and chicken from ten local grocery stores in Shimane Prefecture, Japan, were examined for the presence of Salmonella sp. (Sal), Campylobacter jejuni (Cj), Campylobacter coli (Cc), Yersinia enterocolitica (Ye), and Clostridium perfringens (Cp) from April 1984 to March 1985. A total of 205 isolates of Sal (112 strains), Cj (64 strains), Cc (one strain), Ye (7 strains) and Cp (21 strains) were recovered from 17 beef (14.2%), 31 pork (25.8%) and 94 chicken (78.3%) of 120 samples each. Sal biogroup 1 was found in 8.3% of beef, 13.3% of pork and 35.0% of chicken, Sal biogroup 2 in 0.8% of beef, 4.2% of pork and 14.2% of chicken, Cj in 1.7% of beef and pork and 50.0% of chicken, Cc in 0.8% of pork, Ye serotype 03 was found in 5.0% of pork, and Cp in 1.7% of beef and pork and 10.8% of chicken. These enteropathogens were recovered concomitantly from two pork and 31 chicken samples, especially Sal and Cj. Sal was counted at less than or equal to 10(2)/100 g of beef and pork and at less than or equal to 10(3)/100 g of chicken, Cj was counted at less than or equal to 10(1)/g of beef and pork and at less than or equal to 10(2)/g of chicken, Ye serotype 03 was counted at less than or equal to 10(3)/g of pork, Cp was counted at less than or equal to 10(2)/g of pork and at less than or equal to 10(2)g of chicken, and Cc from pork and Cp from beef were recovered by using enrichment culture. This investigation showed that a second-contamination of Sal and Cj from chicken to beef and pork frequently occurred during the warm months of the year. It was suggested that chicken may become a source of infection with plural organisms of enteric pathogens, especially Sal and Cj, at the same time all the year round, and that pork may be an important source of infection with Ye during the cold months.

Animals↗
PubMed1987

Occurrence of Yersinia spp. in raw beef, pork and chicken.

One hundred and twenty raw ground beef, pork and chicken samples from ten local grocery stores during a one year period were assayed for the presence of Yersinia spp., using direct and postenrichment KOH treatment. Seven thousand and fifty-five different isolates were recovered from 119 (99%) samples of beef and pork and 118 (98%) samples of chicken, including 27 Yersinia enterocolitica serotype 03 biotype 3B phage type 2 (4 pork samples), 4 Y. enterocolitica serotype 03 biotype 4 phage type 8 (3 pork samples), 4,066 Y. enterocolitica biotype 1, 2,194 Yersinia intermedia, 509 Yersinia frederiksenii, and 251 Yersinia kristensenii. Y. enterocolitica serotype 03 was isolated from 6 pork samples, including simultaneously isolation of both biotypes 3B and 4 from one sample. There was the negative correlation between the incidence of isolation of serotype 03 and the environmental temperature, but other environmental Yersinia spp. were frequently isolated through the year. Y. enterocolitica serotype 03 isolates were counted by alkali direct treatment at less than 10(3) cells per g of pork samples, and environmental Yersinia spp. at less than 10(5) cells per g of beef, pork and chicken samples. This may be the first evidence that some pork is contaminated with at least 10(3) Y. enterocolitica serotype 03 cells per g.

Animals↗
PubMed1987

Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl]propionic acid hydrochloride on gastric mucosal barrier.

Effects of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl]propionic acid hydrochloride (TEI-5103, TG-51) on mucosal protection, ion permeability, potential difference, glycoprotein content, and bicarbonate secretion as parameters of the mucosal barrier in rats were studied. TEI-5103 (50-400 mg/kg p.o.) prevented the formation of gastric lesions induced by 75% ethanol, 0.6N HCl, and 0.1N HCl + 60% ethanol. Indometacin (10 mg/kg s.c.) given 30 min prior to TEI-5103 dosing slightly attenuated this protective effect. TEI-5103 (20 mg/ml intragastrically) prevented the increase in acid back-diffusion and ion permeability induced by acetylsalicylic acid (ASA, 5 mg/kg intragastrically). It also inhibited the decrease in mucosal potential difference induced by ASA and resultant lesion formation at 1 h after ASA dosing. TEI-5103 (400 mg/kg p.o.) improved the decrease in mucosal high molecular glycoprotein content induced by ASA (100 mg/kg p.o.), whereas it did not change the normal mucosal glycoprotein content. By intra-luminal perfusion of TEI-5103 (10 and 20 mg/ml/min), an increase in CO2 concentration in the perfusate was observed, suggesting heightened bicarbonate secretion. Its effect at 20 mg/ml/min was same as that of prostaglandin E2 (20 micrograms/ml/min). These findings suggest that TEI-5103 has a cytoprotective effect like prostaglandin and promotes the integrity of the mucosal barrier. These effects of TEI-5103 may contribute to its overall anti-ulcer effect.

Animals↗
PubMed1987

Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)-phenyl] propionic acid hydrochloride on gastric mucosal blood flow.

The effects of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl]propionic acid hydrochloride (TEI-5103, TG-51) on gastric mucosal blood flow (GMBF) in rats, rabbits, and dogs were studied by using hydrogen gas clearance, cross-thermocouple, and 51Cr-labelled erythrocyte methods. TEI-5103 (5 mg/kg i.v.) increased GMBF, measured by hydrogen gas clearance method, in anesthetized rats. At 1-10 mg/kg i.v. it also increased GMBF, measured by cross-thermocouple method, in anesthetized rabbits and dogs. The increasing effect of TEI-5103 was more potent than that of cetraxate. By the intragastric route, TEI-5103 (400 mg/kg) increased the GMBF 1 h after the administration in anesthetized and pylorus-ligated rats. Anti-ulcer doses of TEI-5103 prevented the decrease in the GMBF induced by serotonin or indomethacin in anesthetized rats. The drug also prevented the decrease in gastric mucosal blood volume induced by serotonin. The increase in dog femoral arterial blood flow by TEI-5103 (1-10 mg i.a.) was not affected by propranolol, atropine, diphenhydramine, or aminophylline, nor was it attenuated by pretreatment with indomethacin. TEI-5103, like papaverine, inhibited Ca2+-, PGF2 alpha- and norepinephrine-induced contractions of isolated rabbit coeliac artery. The results indicate that TEI-5103 increases GMBF by acting directly on the gastric microcirculation and that this increasing effect may contribute to the anti-ulcer activity of TEI-5103.

Anesthesia↗
PubMed1987

Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl] propionic acid hydrochloride on gastric mucosa directly from the lumen.

The present experiments were designed to determine if the novel anti-ulcer drug 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl]propionic acid hydrochloride (TEI-5103, TG-51), acts on the gastric mucosa directly from the lumen when given orally. TEI-5103 given orally (50-400 mg/kg) prevented the lesion formation induced by 0.1N HCl + 60% ethanol, but when given intraperitoneally (50-200 mg/kg) or intravenously (40 mg/kg), it did not prevent the formation of lesions. Indomethacin-induced gastric lesions were inhibited by oral administration of TEI-5103, but not by intraduodenal administration. In pylorus-ligated rats, TEI-5103 given intragastrically also inhibited the development of gastric lesions induced by HCl + ethanol. These results suggest that the presence of TEI-5103 in the stomach is necessary to elicit its anti-ulcer effect. In microautoradiographic examination, silver grains corresponding to [14C]-TEI-5103 distributed in the upper part of the mucosa (luminal side) at 0.5 to 4 h after the oral administration. However, when given intraduodenally or intravenously, this high concentration of [14C]-TEI-5103 was not observed in the stomach tissue. When given orally, the content of [14C]-TEI-5103 in rat stomach tissue was about 100 times higher than that in plasma and the time course of distribution was different from that seen in the gastric content. From these results, it seems that TEI-5103 distributes in the gastric mucosa directly from the lumen. In conclusion, TEI-5103, when given orally, distributes in the gastric mucosa as a target issue directly from the lumen; and only the oral and gastric route of administration lead to the anti-ulcer effect.

Administration, Oral↗
PubMed1985

Anti-ulcer effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl) phenyl] propionic acid hydrochloride (TEI-5103).

The anti-ulcer effects of the newly synthesized compound 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)-phenyl]propionic acid hydrochloride (TEI-5103) on experimentally induced ulcers in rats were studied. TEI-5103 at doses of 25 to 400 mg/kg p.o. prevented formation of ulcers induced by serotonin, indomethacin, acetylsalicylic acid or stress (acute ulcer models), its effect being greater against gastric ulcers induced by serotonin. On acetic acid ulcer (chronic ulcer model), TEI-5103 at a daily dose of 200 mg/kg p.o. accelerated the healing of ulcers. TEI-5103 at doses of 100 to 400 mg/kg i.d. did not inhibit gastric acid secretion in pylorus-ligated rats. It markedly increased gastric blood flow in anesthetized rats (at 10-20 mg/kg i.v., measured by the aminopyrine clearance method), and also increased gastric blood flow in anesthetized dogs (at 2.5-10 mg/kg i.v., measured by the cross thermocouple method). These results indicate that TEI-5103 is effective as an anti-ulcer agent increasing gastric mucosal blood flow and possibly promoting the healing process of peptic ulcers.

Acetates↗
PubMed1981

Familial basal ganglia calcifications visualized by computerized tomography.

Intracranial calcification can now be detected easily and precisely with the advent of computerized tomography. A familial case of striopallidal calcification with a rare hereditary pattern of autosomal dominancy is presented. None of the family members, aged from 8 to 62, displayed any neurological abnormality. All female family members had, bilaterally, short fourth metatarsals. Serum calcium and phosphorus values were not abnormal, although such physical findings are compatible with pseudohypoparathyroidism. The family tree suggested autosomal dominant heredity with a penetrance rate of 100%. Our survey revealed that no more than 10 cases of familial striopallidal calcification excluding ours have been reported to date. Only by utilizing CT was the hereditary pattern of our case determined accurately.

Adolescent↗
PubMed1981

Aggregation of platelets induced by novel synthetic secoprostaglandins.

Two series of 8-acetly-12-hydroxyalkadienoic acids and 14-hydroxy-9-oxoalkadienoic acid which can be regarded as 11,12- and 8,12- secoprostaglandin E2 were synthesized and evaluated for their biological properties. Key members of each series, 11,12-(8Ac-HAD) and 8, 12-seco-11-norprostaglandin E2 (14H-OAD), were found to induce platelet aggregation which were inhibited by preincubation of platelet rich plasma with prostaglandin I2 but not inhibited by indomethacin, 8Ac-HAD produced dose-dependent potent contraction of rabbit aorta. Injection of 8Ac-HAD (1 mg/kg) into vein of rat induced sudden death of the animal. Both compounds were stable and platelet aggregating activity did not decrease at least for four hours at 0 degree C. Structure-activity relationship study of the series were carried out. Reduction of the acetyl carbonyl and methoxime formation of 8Ac-HAD lowered platelet aggregating activity, and 8-propionyl substituent and 12-deoxy derivative of 8Ac-HAD showed no activity. 12 (R)-Isomer and dl 12-methyl derivative of 8Ac-HAD retained the platelet aggregating activity. Modification of omega-chain did not cause any essential effect on the activity. Unlike 8Ac-HAD, several modification of 14H-OAD failed to maintain the aggregating activity.

Animals↗